GSK (GSK) stock is in focus as the U.S. FDA expands authorization for the company's Arexvy RSV vaccine to cover adults 18–49. Read more here.

Navigating the labels on vitamins, supplements, and medicines can be confusing. Terms like “FDA approved,” “FDA tested,” and “meets FDA standards” are meant to communicate safety and quality, but ...

The FDA proposes front-of-package "Nutrition Info boxes" to highlight saturated fat, sodium, and added sugars. The initiative aims to combat chronic diseases and promote healthier food choices. Large ...

Sarah Todd returned to reporting in January 2025 after being assignment editor at STAT since October 2022. You can reach Sarah on Signal at sarahlizchar.47. A new government proposal to display ...

GSK's RSV jab, Arexvy will now compete for market share with Pfizer’s Abrysvo and Moderna’s mRESVIA across the high-risk ...

Evidence suggests commercial health plans are more likely to delay specialty drug coverage decisions in response to FDA ...

WASHINGTON — The Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings ...

With President Trump back in the Oval Office and Robert F. Kennedy possibly to follow at the Department of Health and Human Services, it’s hard to say what’s in store for the Food and Drug ...

Vanda Pharmaceuticals’ seven-year ambition to score a coveted label expansion for sleep drug Hetlioz has taken an unusual turn, with the FDA acquiescing to a formal hearing on the matter. | The ...